Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

NCT07008118

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic-Florida Jacksonville, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

NCT04227847

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Dept. of Medicine, UAB ONeal Comprehensive Cancer Center Birmingham, Alabama, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 53 locations
View Trial Details
Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Comprehensive Cancer Center (CCC) Duarte, California, United States
  • Providence Medical Group Santa Rosa, California, United States
  • Cancer & Blood Research Center Whittier, California, United States
View all 156 locations
View Trial Details
Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT06542250

Conditions
B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Hackensack, New Jersey, United States
View all 31 locations
View Trial Details
Recruiting

Long-term Follow-up Study of BRL-101 for TDT

NCT06298630

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
  • Shenzhen Children 's Hospital Shenzhen, Guangdong, China
  • No. 923 Hospital of Joint Support Force of Chinese People 's Liberation Army Hospital Nanning, Guangxi, China
View Trial Details

Related conditions